8-K

Company

TScan Therapeutics, Inc.

Filed

August 20, 2025

Period of Report

August 14, 2025

Accession Number

0001193125-25-184083

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →